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Mycobacteria contain genes for several DNA ligases, including ligA, which encodes a NAD-dependent
enzyme that has been postulated to be a target for novel antibacterial compounds. Using a homologous
recombination system, direct evidence is presented that wild-type ligA cannot be deleted from the chromosome
of Mycobacterium smegmatis. Deletions of native ligA in M. smegmatis could be obtained only after the integra-
tion of an extra copy of M. smegmatis or Mycobacterium tuberculosis ligA into the attB site of the chromosome,
with expression controlled by chemically inducible promoters. The four ATP-dependent DNA ligases encoded
by the M. smegmatis chromosome were unable to replace the function of LigA. Interestingly, the LigA protein
from M. smegmatis could be substituted with the NAD-dependent DNA ligase of Escherichia coli or the
ATP-dependent ligase of bacteriophage T4. The conditional mutant strains allowed the analysis of the effect of
LigA depletion on the growth of M. smegmatis. The protein level of the conditional mutants was estimated by
Western blot analysis using antibodies raised against LigA of M. tuberculosis. This revealed that a strong
overproduction or depletion of LigA did not affect the growth or survival of mycobacteria under standard
laboratory conditions. In conclusion, although NAD-dependent DNA ligase is essential for mycobacterial
viability, only low levels of protein are required for growth. These findings suggest that very efficient inhibition
of enzyme activity would be required if NAD-dependent DNA ligase is to be useful as an antibiotic target in
mycobacteria. The strains developed here will provide useful tools for the evaluation of the efficacy of any
appropriate compounds in mycobacteria.
Tuberculosis (TB) remains a major threat to public health. It
is an important infectious disease, causing high morbidity and
mortality worldwide, and the situation is made even worse by
the emergence of drug-resistant strains of Mycobacterium tu-
berculosis (4). For example, multidrug-resistant (MDR) TB
(resistant at least to rifampin and isoniazid) takes longer to
treat (up to 2 years) with second-line drugs, which are expen-
sive and have side effects. Even worse is extensively drug-
resistant TB, which is resistant to first- and second-line drugs
(MDR plus resistance to any fluoroquinolone and at least one
of three injectable second-line drugs: capreomycin, kanamycin,
or amikacin). Thus, options for treatment are becoming seri-
ously limited, returning TB control to the preantibiotic era
(3, 20). Drug resistance in M. tuberculosis is not caused by a
universal mechanism for all drugs but can be caused by
mutations of various chromosomal genes, as identified for
MDR occurrence due to the sequential accumulation of
mutations in different genes that provide resistance to indi-
vidual drugs. The mutations connected to resistance can
appear in targets of current drugs (e.g., inhA and kasA for
isoniazid, rpoB for rifampin, and embCAB for ethambutol)
or enzymes required for the intracellular activation of cur-
rent drugs (katG for isoniazid, pncA for pyrazinamide, and
etaA for ethionamide) (34). These concerns lead to the
conclusion that the identification of novel, sensitive targets
or new drugs is necessary for the control of drug-resistant
forms of TB.
A requirement for an antibacterial enzyme target is that it be
essential for the organism and not present in the host. One
such candidate has been proposed to be NAD-dependent
DNA ligase (5, 32). DNA ligases are essential constituents of
all organisms due to their critical roles in DNA replication and
repair. The mechanism of DNA ligation shares common fea-
tures regardless of the cellular origin of the enzyme, with a key
step being the formation of a covalent DNA ligase-adenylate
intermediate. Importantly, two classes of DNA ligase that are
categorized by whether NAD or ATP is used as the source of
adenylate have been identified. While the essential DNA
ligases of bacteria are NAD dependent, those used in
eukaryotes, archaea, and viruses are ATP dependent. It is this
distribution of cofactor specificity that has led to the suggestion
that NAD-dependent DNA ligases may be exploited as useful
new targets for broad-spectrum antibacterial compounds (5,
24, 29, 32). Indeed, recent studies have begun to make impor-
tant progress in identifying small molecules that have some
specificity towards the inhibition of NAD-dependent DNA
ligases (2, 26–28).
Although NAD-dependent DNA ligases appear to be pro-
duced in all bacteria, some bacteria encode additional ATP-
dependent versions of the proteins (5, 24, 29, 32). This com-
plicates potential strategies to target NAD-dependent DNA
ligases with antibiotics, as it is not clear whether the ATP-
dependent enzymes would influence the efficacy of any com-
pound. Such factors are particularly relevant to mycobacteria,
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because multiple DNA ligases are encoded within their ge-
nomes (Fig. 1). Mycobacterial genomes carry a single gene,
ligA, that is homologous to NAD-dependent DNA ligases,
with the activity of its expressed product confirmed by in vitro
studies (10, 26–28, 33). Three different types of ATP-depen-
dent DNA ligases are encoded in the genomes of mycobacte-
ria, and the biochemical activities of these proteins have also
been confirmed (9, 10, 31).
The potential for antibiotics to target NAD-dependent
DNA ligases relies on the fact that these enzymes are believed
to be essential for all bacteria due to their participation in
DNA replication. However, it is difficult to establish this indis-
pensability in a definitive manner, which is a fundamental
requirement if these enzymes are going to be assessed as an-
tibiotic targets. In this report, we undertake a series of exper-
iments that prove directly that ligA is essential in Mycobac-
terium smegmatis. We demonstrate that this gene can be
complemented by non-host NAD-dependent DNA ligases
and the ATP-dependent DNA ligase from bacteriophage T4.
A detailed analysis of the amount of DNA ligase in various
FIG. 1. DNA ligases of mycobacteria, E. coli, and bacteriophage T4. A schematic diagram of conserved domains within the various DNA ligases
used in this study is shown. The number of amino acids in each specific protein is indicated. Approximate relative positions of domains conserved
within more than one of the proteins are shown by the shaded regions. Domains were identified from their reference within the Pfam (8) or
SMART (15) database, as indicated. (A) NAD-dependent ligases from M. smegmatis (MsLigA), M. tuberculosis (MtLigA), and E. coli (EcLigA).
(B) ATP-dependent DNA ligases from M. smegmatis (MsLigB, MsLigC1, MsLigC2, and MsLigD) and bacteriophage T4 (T4Dnl).
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strains identifies that the level of protein can vary by around
10-fold, with little effect on growth under standard laboratory
conditions. Strains produced during this study will be useful in
any detailed evaluation of antibiotics targeting NAD-depen-
dent DNA ligases.
MATERIALS AND METHODS
Bacterial strains and growth conditions. All strains used in this study were
based on M. smegmatis mc2155 (25) and were cultured in Middlebrook 7H9 broth
supplemented with albumin-dextrose-sodium chloride or NB broth (8.0 g/liter
nutrient broth [Difco], 10.0 g/liter glucose). As required, further additions in-
cluded 0.2% Tween 80 (pH 6.0 to 6.2), 50 g/ml hygromycin, 7.5 g/ml genta-
micin, and 25 g/ml kanamycin. Mycobacterial transformants were selected on
Middlebrook 7H10 agar plates enriched with albumin-dextrose-sodium chloride
containing kanamycin (25 g/ml), gentamicin (7.5 g/ml), or hygromycin (50
g/ml).
Gene cloning strategies. Standard molecular biology protocols were used for
all cloning protocols (22). All PCR products were obtained using thermostable
ExTaq polymerase (Takara, Japan), cloned initially into a TA vector (pGEM-T
Easy; Promega), and then released by digestion with appropriate restriction
enzymes before cloning into the final vectors. To facilitate subcloning into ex-
pression vectors, restriction enzyme recognition sites were incorporated into the
sequence of the primers. The plasmids used in this work are listed in Table 1.
Construction of ligA gene replacement vector. Following strategies reported
previously that deleted DNA ligase genes in M. smegmatis (12), a suicidal re-
combination delivery vector was constructed to perform unmarked deletions in
the ligA gene (MSMEG2361) of M. smegmatis. The vector carried the 5 end of
ligA (68 bp) with the upstream region amplified with primers A-GR1 and A-GR2
(Table 2) connected to the 3 end of the gene (936 bp) and with the downstream
region amplified with A-GR3 and A-GR4 primers (Table 2). Note that this
cloning results in the 5 and 3 fragments of the gene being ligated out of frame,
allowing expression of nonfunctional protein only.
Construction of complementation plasmids. M. smegmatis genes (ligA, ligB
[MSMEG2280], ligC1 [MSMEG6264], ligC2 [MSMEG6263], and ligD
[MSMEG5550]), M. tuberculosis ligA (ligAMt) (Rv3014), Escherichia coli ligA
(ligAEc) (EC2345), and DNA ligase of bacteriophage T4 (M32518) were ampli-
fied by PCR and cloned downstream from the Pami promoter (Tables 1 and 2).
Mycobacterial ligases were cloned first into the BamHI-XbaI sites of pJam2, and
the cloned genes and Pami promoter were then excised with HindIII and XbaI
and cloned into the integration vector pMV306HygR or pMV306GmR. ligAEc was
introduced into the single XbaI site of pMV306-Pami under the control of the
acetamidase promoter. The gene for T4 DNA ligase was introduced into the
BamHI site of pJam2, excised from this vector with HindIII, and cloned into
pMV306. Finally, ligA of M. smegmatis was cloned into pSE100 downstream from
the Ptet promoter (Tables 1 and 2).
Testing of ligA essentiality and engineering of conditional mutants. A two-step
recombination protocol (12, 17) was used to obtain single-crossover (SCO)
strains carrying wild-type (wt) and disrupted ligA (ligA) at its native locus on the
chromosome. Using the strategy outlined in Fig. 2A, the suicidal recombination
plasmid DNA (p2NILligA) was treated with NaOH (0.2 mM) and integrated
into the M. smegmatis mc2155 chromosome by homologous recombination. The
resulting SCO recombinant mutant colonies were blue, Kanr, and sensitive to
TABLE 1. Plasmids used in this study
Plasmid Description Source or reference
Cloning vectors
pGemTEasy T/A cloning Promega
pMV306 Mycobacterial integrating vector, Hygr Med-Immune Inc.
p2NIL Recombination vector, nonreplicating in mycobacteria, Kanr 17
pGoal17 Source of PacI cassette, Ampr 17
pJam2 Shuttle vector carrying inducible Pami promoter, Kan
r 30
PMV306GM pMV306 with defective Hygr gene (digested with EcoRI, filled-in resultant cohesive
ends, and self-ligated) carrying Gmr gene in KpnI site
This study
pMVPami pMV306 with Pami promoter of pJam2 cloned into HindIII-XbaI restriction sites This study
pMV306tetR Mycobacterial integrating vector carrying tetracycline repressor, Kmr 7
pSE100 Shuttle vector carrying inducible Ptet promoter, Hyg
r 7
Vectors used for gene
replacement
pMK104 M. smegmatis 5 ligA PstI-HindIII fragment including 5 end and its upstream region
(1,754 bp) in p2NIL, Kanr
This study
pMK106 M. smegmatis ligA HindIII-BamHI fragment including 3 end and its downstream
region (1,741 bp) in pMK104, Kanr
This study
pMK107 pMK106 with PacI cassette from pGoal17, Kanr This study
pMK140 pMK104 with Hygr gene cloned between 5 and 3 fragments of ligA (ligA::Hygr),
Kanr Hygr
This study
pMK141 pMK140 with PacI cassette from pGoal17, Kanr Hygr This study
Overproduction vectors
pMK114 ligAMs under Pami promoter in pJam2, Kan
r This study
pMK129 ligAMs under Pami promoter in pJam2, Kan
r This study
pMKB144 ligBMs under Pami promoter in pJam2, Kan
r This study
pMKC146 ligC1Ms under Pami promoter in pJam2, Kan
r This study
pMKC148 ligC2Ms under Pami promoter in pJam2, Kan
r This study
pMK113 ligDMs under Pami promoter in pJam2, Kan
r This study
pJamligT4 bacteriophage T4 ligase under Pami promoter in pJam2, Kan
r This study
pMK124 ligAMs under Pami promoter of pMK114 cloned in pMV306, Hyg
r This study
pMK130 ligAMt under Pami promoter of pMK129 cloned in pMV306, Hyg
r This study
pMK155 ligBMs under Pami promoter of pMKB144 cloned in pMV306GM, Gm
r This study
pMK152 ligC1Ms under Pami promoter of pMKC146 cloned in pMV306GM, Gm
r This study
pMK154 ligC2Ms under Pami promoter of pMKC148 cloned in pMV306GM, Gm
r This study
pMK150 ligDMs under Pami promoter of pMK113 cloned in pMV306GM, Gm
r This study
pMVligAEc ligAEc cloned under control of Pami promoter in pMVPami, Hyg
r This study
pMVligT4 Bacteriophage T4 ligase under Pami promoter of pJamligT4 cloned in pMV306, Hyg
r This study
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sucrose. Additionally, the suicidal recombination plasmid (p2NILligA) was
enriched with the Hygr gene cloned in a single HindIII site of ligA (ligA::hyg)
and introduced into M. smegmatis. The resulting SCO-2 mutant colonies were
blue, Kanr, Hygr, and sensitive to sucrose. The SCO strains were further pro-
cessed to select for double-crossover (DCO) mutants that were white, Kans, and
resistant to sucrose (2%). PCR was used to identify the presence of ligA or ligA
in resultant DCOs.
Further experiments used the strategies outlined in Fig. 2B and Fig. 3 to
introduce the complementation plasmids into SCO strains. The resultant strains
SCO-Pami ligAMs, SCO-Ptet ligAMs, SCO-Pami ligAMt, SCO-Pami ligAEc, SCO-Pami
ligB, SCO-Pami ligC1, SCO-Pami ligC2, SCO-Pami ligD, and SCO-Pami T4Dnl were
processed to select for DCO mutant strains in the presence of inducers (0.2%
acetamide and 25 ng/ml anhydrotetracycline for Pami and Ptet, respectively). If
DCOs carrying ligA were not identified during the processing of SCO strains
with complementing genes, the complemented SCO-2 strains (SCO-2 Pami ligB,
SCO-2 Pami ligC1, SCO-2 Pami ligC2, and SCO-2 Pami ligD) were processed for
DCO strains. This approach allowed the attempted selection of DCOs exclu-
sively carrying ligA::hyg at the native locus, with the resultant resistance to
hygromycin allowing the detection of mutated strains even if they appeared at
very low efficiencies.
For all SCO and DCO strains, PCR and Southern hybridization were used to
identify the presence of ligA or ligA at the native locus on the chromosome. A
hybridization probe (to the 3 end of ligA) was generated by PCR (using primers
A-GR3 and MsA-r) (Table 2) and labeled by a nonradioactive primer extension
system (DIG-labeling system; Amersham).
Preparation of antibodies against LigAMt. Cloning and purification of a re-
combinant form of LigAMt has been described previously (33). Note that this
protein contains a His10 tag within an extra 21 amino acids (2.5 kDa) at the N
terminus. LigAMt was purified using nickel affinity chromatography (His-Bind
column; Novagen) and was used to raise a primary rabbit polyclonal antibody
(Davids Biotechnologie).
Total protein isolation and Western blotting. Preparation of mycobacterial
cell lysates by bead beating (using 0.1-mm zirconia beads) and detection of LigA
by Western blotting using polyclonal antibodies were done essentially as de-
scribed previously (6). The total protein concentration was determined by the
Bradford method (22). For quantitative immunoblotting, the same concentration
of total protein extracts was loaded onto sodium dodecyl sulfate-polyacrylamide
gels. Western blots were processed using the Amersham Pharmacia ECL chemi-
luminescence kit and protocol. The LigA bands were visualized on Hyperfilm
ECL (Amersham) and scanned for densitometry with FluorChem (Alpha Inno-
tech Corp.).
RESULTS
NAD-dependent DNA ligase is essential for viability of
mycobacteria. NAD-dependent DNA ligases are highly con-
served across all bacterial genomes (32), allowing ready iden-
tification of homologous genes by bioinformatics analysis (Fig.
1). The genomes of fast- and slow-growing mycobacteria carry
a single gene that is homologous to ligA, with the activity of
their expressed NAD-dependent DNA ligases confirmed by
in vitro studies (10, 27, 28, 33). Since NAD-dependent DNA
ligases are not present in the genomes of cells targeted by
mycobacterial pathogens, they have been postulated to be a
potential target for new antibiotics (5, 24, 29, 32). The poten-
tial usefulness of this approach is dependent on the extent to
which these enzymes are essential for the viability of mycobac-
teria.
To allow a careful evaluation of the essentiality of bacterial
ligA, we used M. smegmatis as a model experimental system. A
two-step recombination protocol (17) was used to construct
SCO strains carrying both wt ligA and a mutated copy of ligA
(ligA). Further processing of SCO strains for a second step of
recombination should generate strains carrying either wt ligA
or only the ligA gene (mut-DCO) (Fig. 2A). The identifica-
tion of mut-DCO strains would be possible only if ligA is not
essential for the viability of mycobacteria. PCR analysis of
more than 50 individual DCO colonies identified wt DCO
exclusively, confirming that knockout mutations in ligA are
lethal for mycobacteria.
Even though the wt gene is essential, we wondered if it
TABLE 2. Primer sequences used for PCR amplification of gene sequences
Amplified region Primer Sequence Productsize (bp)
Primers used to amplify DNA for
targeted gene replacement
ligA 5 flanking region, sense A-GR1 5-CTGCAGTCTCGCGCGTCGCGCGCTCG-3 1,754
ligA 5 flanking region, reverse A-GR2 5-AAGCTTCGCCGCTCGTCGGCGTCAGG-3
ligA 3 flanking region, sense A-GR3 5-AAGCTTGGCGACACCGTGGTGATCCGC-3 1,741
ligA 3 flanking region, reverse A-GR4 5-GGATCCAGCCGAGACCACAGGGCGGG-3
Primers used to clone genes for
complementation experiments
ligAMs gene, sense MsA-s 5-GGATCCGTGAGCGAGAAGGCAACCG-3 2,106
ligAMs gene, reverse MsA-r 5-TCTAGACTACTCGGCCGGCTCGACC-3
ligBMs gene, sense MsB-s 5-AGATCTATGGATGTCCGACCCGCG-3 1,566
ligBMs gene, reverse MsB-r 5-TCTAGATCAGTCGCGCTCGTAGAAC3
ligC1Ms gene, sense MsC1-s 5-GGATCCATGGACCTGCCCGTGCTGC-3 1,065
ligC1Ms gene, reverse MsC1-r 5-TCTAGACTAAACCCGGCACGATGTC-3
ligC2Ms gene, sense MsC2-s 5-AGATCTATGGGAAGGATGGACTTGC-3 1,056
ligC2Ms gene, reverse MsC2-r 5-TCTAGATCACTGTTCCTCCAGCACG-3
ligDMs gene, sense MsD-s 5-GGATCCGTGGCGAGGCATCCTTGGG-3 2,289
ligDMs gene, reverse MsD-r 5-TCTAGACTATTCCCACACAACCTC-3
ligAMt gene, sense MtbA-s 5-AGATCTGTGAGCTCCCCAGACGCCG-3 2,076
ligAMt gene, reverse MtbA-r 5-TCTAGATTACGTTCGTGACGCGGG-3
ligAEc gene, sense EcA-s 5-TCTAGAATGGAATCAATCGAACAAC-3 2,016
ligAEc gene, reverse EcA-r 5-TCTAGATTAGCTACCCAGCAAACGC-3
T4Dnl gene, sense T4-s 5-GGATCCATGATTCTTAAAATTCTGAACG-3 1,464
T4Dnl gene, reverse T4-r 5-GGATCCTCATAGACCAGTTACCTCATG-3
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would be possible to delete it from the bacterial chromosome
if another copy of the gene at a different location supported the
expression of required protein. Moreover, by controlling ex-
pression from the additional gene by an inducible promoter, a
conditional mutant might be obtained. To prepare such mutant
strains, M. smegmatis ligA (ligAMs) and M. tuberculosis ligA
(ligAMt) were cloned under the control of the tetracycline (Ptet)
or acetamidase (Pami) promoter. These recombinant genes
were introduced into SCO strains by integration into the host
chromosome (genes induced from Pami) or as a self-replicating
vector (genes induced from Ptet). The resultant mutant strains
(SCO-Ptet/Pami ligAMs/ligAMt) carrying wt ligA, ligA, and Ptet/
Pami ligAMs/ligAMt were processed in the presence of the ap-
propriate inducer to obtain DCO mutant strains. mut-DCO
strains carrying ligAMs/ligAMt controlled by the Pami or Ptet
promoter as the sole intact copy of ligA were identified by PCR
and Southern hybridization (Fig. 2B). The successful engineer-
ing of such strains confirmed the essentiality of ligA in myco-
bacteria and showed that ligAMt can replace its M. smegmatis
ortholog.
NAD-dependent DNA ligase cannot be replaced by over-
production of ATP-dependent DNA ligases of mycobacteria. In
addition to an NAD-dependent DNA ligase, mycobacteria
encode three different ATP-dependent ligases (9, 10, 31). In
fact, M. smegmatis has the potential to express four ATP-
dependent DNA ligases since it has two closely related copies
of ligC (Fig. 1). BLAST analysis identified that each of these
ATP-dependent DNA ligases contains a domain that is well
conserved in other DNA ligases, as indicated by their Pfam
nomenclature (8): Pfam01068 relates to the conserved catalytic
(adenylation) domain of DNA ligases. Notably, this domain is
present in the ATP-dependent DNA ligase of enterobacterio-
FIG. 2. NAD-dependent ligA is essential for viability of M. smegmatis. (A) A deleted version of ligA (ligA) of M. smegmatis was constructed
by PCR and introduced into the suicide recombination vector p2NIL. SCO mutants carrying both ligA and ligA were obtained by the integration
of plasmid DNA (p2NILligA) into regions of the chromosome that flank the gene of interest. SCO mutant strains were processed directly for
DCO mutant strains. The genotype of selected strains (50) was confirmed by PCR, indicating that all DCO strains carried wt ligA exclusively.
(B) SCO strains from A were enriched with intact ligA from M. smegmatis or M. tuberculosis controlled by an inducible promoter (Pami
ligAMs/ligAMt). The genotype of selected strains was confirmed by PCR and Southern hybridization analysis, indicating that DCO strains were both
wt (ligA) and mutant type (ligA). Numbers above the lanes of each gel represent the following samples: 1, 1-kb DNA ladder; 2, M. smegmatis wt
control; 3, p2NILligA plasmid; 4, SCO mutant strains. DCO mutant strains are indicated in the figure, with those containing ligA highlighted
by an asterisk (*). Note that the middle PstI recognition site (A) was present within the deleted region of ligA (ligA), thus causing the ligA band
detected by Southern hybridization to be larger than the wt ligA band. The Southern hybridization probe was amplified using the 3 undeleted end
of ligA.
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phage T4 (Fig. 1), which is able to replace the function of
ligAEc (13). Although the essential nature of ligA shows that
the ATP-dependent DNA ligases cannot normally replace
LigA, we wondered if these proteins may be able to replace the
function of LigA if they were overexpressed. Such a phenom-
enon could lead to the selection of resistant strains if LigA
were to be inactivated with an antibiotic drug. Therefore, by
following the procedures outlined above to obtain conditional
mutants, we assessed the potential redundancy of function
between the mycobacterial DNA ligases by testing whether
ligA is still essential in genetic backgrounds that overexpress
ATP-dependent ligases.
FIG. 3. NAD-dependent ligA of M. smegmatis can be substituted with NAD-dependent ligA of E. coli or ATP-dependent ligase of enterobacte-
riophage T4. SCO strains carrying both ligA and ligA (Fig. 2) were enriched with ligAEc (A) or ligT4 (B) controlled by a Pami promoter. DCO mutant
strains resulting from the processing of these SCO strains were both wt (ligA) and mutant type (ligA). The genotype of selected DCO strains was
confirmed by PCR (A and B) and Southern hybridization (C) analyses. Numbers above the lanes of each gel represent the following samples: 1, 1-kb
DNA ladder; 2, M. smegmatis wt control; 3, p2NILligA plasmid; 4, SCO mutant strains; 5, DCO mutant strains carrying wt ligA; 6, DCO mutant strains
carrying ligA. In the Southern hybridization shown in C, 6A and 6B represent the complementation by ligAEc and ligT4, respectively. Note that the
middle PstI recognition site (A) was present within the deleted region of ligA (ligA), thus causing the ligA band detected by Southern hybridization
to be larger than the wt ligA band. The Southern hybridization probe was amplified using the 3 undeleted end of ligA.
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To simplify the DCO screening and to allow the examination
of a larger number of colonies, the SCO strain was modified by
the introduction of a hygromycin resistance cassette into ligA
(ligA::Hygr). This allowed the resultant mut-DCO and wt
DCO to be distinguished by supplementation of hygromycin B
into the screening media, with only the mut-DCO strains being
able to grow under such conditions. The ATP-dependent li-
gases of M. smegmatis (ligB, ligC1, ligC2, and ligD) were cloned
under the control of the Pami promoter and introduced into the
attB site of an SCO strain. Although we did not have antibodies
to test of the level of expression for each of these proteins, the
expression system is known to be efficient (6), and it clearly
worked for the ligA homologs (Fig. 2A). The screening for
DCO strains was performed in the presence of the Pami in-
ducer and in the presence or absence of hygromycin B. No
colonies with the expected DCO phenotype (white and Kms)
grew in the presence of hygromycin B in the media. For SCO
strains carrying a gene for each of the ATP-dependent ligases,
all DCO strains obtained without hygromycin revealed the wt
genotype (wt DCO) when verified by PCR (data not shown).
These results demonstrate that ATP-dependent DNA ligases
cannot substitute for NAD-dependent enzymes, again con-
firming the essentiality of ligA in M. smegmatis.
E. coli NAD-dependent DNA ligase and ATP-dependent
ligase of bacteriophage T4 can substitute for LigA in myco-
bacteria. The data described above show that the NAD-
dependent DNA LigA of M. smegmatis can be substituted with
its ortholog from M. tuberculosis. This result is expected since
there is very close homology across mycobacterial gene se-
quences. Since mycobacterial genomes are GC rich, we won-
dered if they may have evolved specialized versions of ligA. We
tested whether complementation of LigAMs might extend to
gene sequences that are less well conserved. In these experi-
ments, we used genes that are much less GC rich, namely,
those that are the paradigms for DNA ligases that participate
in replication: the NAD-dependent DNA LigA from the
gram-negative bacterium E. coli and the ATP-dependent ligase
from enterobacteriophage T4. Both genes were amplified by
PCR, cloned under the control of the Pami promoter, and
introduced into the attB site of an SCO strain already carrying
ligA. The resultant strains carrying wt ligA, ligA, and either
ligAEc or the ATP-dependent ligase of bacteriophage T4
(ligT4) expressed from the Pami promoter were processed to
obtain DCO strains. PCR and Southern hybridization analysis
revealed mut-DCO strains without an intact copy of ligAMs
(Fig. 3). Thus, ligAMs could be complemented with either
ligAEc or ligT4. Significantly, in the latter case, the resultant
strains of M. smegmatis carry genes for ATP-dependent DNA
ligases exclusively.
The replacement of LigAMs with its counterpart from M.
tuberculosis or E. coli did not produce a significant effect on the
growth of M. smegmatis (Fig. 4A and B). Mutant strains car-
rying ligT4 to complement ligA from M. smegmatis grew more
slowly, taking an extra 24 h to reach stationary phase, espe-
cially if its expression was not induced to a high level with
acetamide (Pami inducer) (Fig. 4C). The growth dynamics of
the strain carrying ligT4 were most affected by a delay in
achieving exponential growth. Since each culture was inocu-
lated with the same number of actively growing cells, such a
delay in growth is likely to result from an increase in doubling
time compared to the wt strain. Although the specific reasons
behind this delay are not yet known, it is clear that M. smeg-
matis is sensitive to the type of replicative DNA ligase that is
present within the cell.
The growth of M. smegmatis is insensitive to the level of
LigA. A reliable antibiotic target should be essential for bac-
terial viability, and a significant decrease in its activity should
have a similarly significant effect on bacterial growth. To assess
this property of LigAMs, the constructed conditional mutant
strains carrying a single ligA gene under the control of induc-
ible promoters (Ptet/Pami) were used to analyze the influence of
the LigA amount on bacterial growth.
FIG. 4. M. smegmatis carrying only ATP-dependent ligases is de-
fective in growth. The M. smegmatis wt control strain (wt) and condi-
tional mutant strains carrying ligase genes driven by Pami promoter
were grown in Middlebrook 7H9/oleic acid-albumin-dextrose catalase
medium with and without the induction of Pami. All conditional mutant
strains carried a single intact copy of the named ligA substituting for a
deletion in M. smegmatis ligA as follows: (A) ligA-Pami ligAMs, ligA
mutant complemented with M. smegmatis ligA; (B) ligA-Pami ligAEc,
ligA mutant complemented with E. coli ligA; (C) ligA-Pami ligT4,
ligA mutant complemented with the gene for T4 DNA ligase. The
growth of each culture was monitored by optical density analysis. Growth
experiments were repeated three times, with the representative result
being presented in the figure. OD600, optical density at 600 nm.
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Strains were grown as required, and the level of LigA was
estimated using polyclonal antibodies raised against a recom-
binant form of LigAMs. Initial experiments confirmed that this
antibody had cross-reactivity with native LigA expressed from
the chromosome of M. smegmatis (data not shown). The mu-
tant strains were able to grow without inducer supplementing
the media, indicating that both promoters are leaky and allow
low levels of constitutive expression. The protein analysis
showed that the Ptet promoter leaks more than Pami, but its
fully induced level of expression was much higher (Fig. 5).
These observations are likely to be due to the fact that Ptet
expressed genes from plasmid DNA (five to six copies) but that
Pami expressed genes from a single copy in the chromosome.
The strains expressing different levels of LigA protein were
cultured: the wt M. smegmatis strain, the ligA-Pami ligA strain
growing without acetamide in the medium, and the ligA-Ptet
ligA strain growing in medium supplemented with anhydrotet-
racycline. The growth of these three strains was determined by
optical density measurement, and the level of LigA was deter-
mined by Western blot analysis (Fig. 5). The Western blot
analysis revealed a large overproduction of LigA in the ligA-
Ptet ligA strain growing in the presence of inducer, up to 11
times more than that of the wt strain as detected by densitom-
etry (data not shown). By contrast, very low amounts of LigA
were present in the ligA-Pami ligA mutant strain (about three
times less than the wt strain). However, the growth dynamics of
the strains were not affected by the different levels of LigA and
were comparable to the growth of the wt strain (Fig. 5).
It is likely that drug treatments decrease the level of func-
tional target protein, which inhibits or prevents bacterial
growth over long-term exposure. To determine if the depletion
of LigA over long periods may affect the viability of M. smeg-
matis, the wt strain and ligA-Pami ligA mutant strains were
incubated for 3 weeks. No inducer was added to the medium
in this experiment, so there was limited expression of LigA
in the ligA-Pami ligA strains. The number of viable cells was
counted, and the level of LigA was determined by Western
blot analysis. During these experiments, lasting for 21 days,
no significant differences in viability were observed between
a wt strain carrying normal levels of LigA and mutant strains
carrying as little as 30% of LigA (data not shown). Thus, the
results presented here suggest that any compound targeting
LigA would need to reduce the activity of this essential
enzyme by more than 70% if is to be able to act effectively
as an antibiotic.
DISCUSSION
Mycobacteria contain genes for several ATP-dependent
DNA ligases and a single NAD-dependent DNA ligase en-
coded by ligA. Previous studies are consistent with ligA being
essential in M. smegmatis (9) and M. tuberculosis (23). The data
presented here support these suggestions and provide the most
direct genetic evidence yet obtained that NAD-dependent
DNA ligases are essential in bacteria. Thus, these experiments
in mycobacteria support proposals from experiments with
other bacteria, including E. coli (14), Salmonella enterica sero-
var Typhimurium (18), Bacillus subtilis (19), and Staphylococ-
cus aureus (11). These findings confirm that NAD-dependent
DNA ligases may provide useful targets for broad-spectrum
antibacterial compounds (5, 24, 29, 32) and suggest that it is
worthwhile to focus effort on identifying specific inhibitors of
them (2, 26–28).
Complementation of M. smegmatis ligA strains by expres-
sion of LigA from E. coli confirms that the function of this
protein is conserved across organisms that are widely divergent
in evolutionary terms. By contrast, the mycobacterial ATP-
dependent DNA ligases are unable to replace the function of
LigA. This is not due simply to the use of ATP as the cofactor
since the M. smegmatis ligA strains are complemented by the
ATP-dependent DNA ligase of bacteriophage T4. In terms of
the protein sequences of different DNA ligases, the catalytic
region is well conserved among all ATP-dependent DNA li-
gases used in this study (Fig. 1). Since the M. smegmatis ATP-
dependent DNA ligases were unable to produce the same
complementation as the T4 DNA ligase, this shows that some
other parts of their polypeptide sequences influence their ac-
tivity and prevent them from functioning in DNA replication.
This observation is consistent with findings that the ATP-de-
FIG. 5. Growth of M. smegmatis is insensitive to the amount of expressed LigA. As shown in the panel on the right, optical density (OD) analysis
determined the extent of growth of M. smegmatis strains carrying a natural level of LigA (lane 1, wt strain), a low level of LigA (lane 2, ligA-Pami
ligAMs, without inducer), and an overproduced level of LigA (lane 3, ligA-Ptet ligAMs, with inducer). In the left panel, the level of LigA was
determined by Western blot analysis with antibodies raised against LigA of M. tuberculosis. For each lane, 12 g of total proteins was loaded.
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pendent DNA ligases of bacteria participate in DNA repair
pathways rather than DNA replication (1, 24, 29).
The observation that the M. smegmatis ligA strains can be
complemented by the ATP-dependent DNA ligase of bacte-
riophage T4 is consistent with findings for other bacteria (13,
18, 21). Although bacteriophage T4 does not naturally infect
mycobacteria, this observation raises the possibility that if
genes encoding ATP-dependent ligases were transferred to the
mycobacterial chromosome (e.g., by horizontal gene transfer),
they may be able to substitute for LigA and therefore impact
the targeting of DNA ligases by antibiotics. On the other hand,
horizontal transmission of resistance factors is not generally
seen with tubercle bacilli.
Evaluation of the expression of LigA shows that M. smeg-
matis grows similarly across levels of expression of the protein
that varied by approximately 10-fold. This is reminiscent of
findings for E. coli, where it has been estimated that 1 to 3% of
LigA is sufficient to support growth under laboratory condi-
tions (14, 16). It is not fully understood why bacterial cells have
evolved to express such an additional “capacity” of DNA ligase
as a standard, but it may relate to the fact that these enzymes
participate in many aspects of DNA metabolism. The activity
of ligase required for standard laboratory conditions may be
relatively low, since the enzyme will be involved primarily with
DNA replication. However, at certain times, such as after
extensive DNA damage, the increased flux through DNA re-
pair/recombination pathways will mean that the cells require a
much larger DNA ligase activity. The cells may therefore find
it an advantage to have a built-in extra capacity so that they can
respond quickly to times of increased DNA stress. Future
experiments will test the effects of DNA damage on the strains
produced in this study.
The high level of identity between M. smegmatis and M.
tuberculosis DNA ligases and the complementation of the M.
smegmatis ligA mutant strain with intact ligAMt without a
detectable effect on viability or growth rate suggest that our
findings are not limited to nonpathogenic mycobacteria. Our
experiments with complemented strains of M. smegmatis raise
at least two important issues that should be evaluated in the
context of targeting NAD-dependent DNA ligases with anti-
biotics. First, complementation with DNA ligase from bacte-
riophage T4 raises the possibility that proteins other than myco-
bacterial LigA may influence the efficacy of an inhibitor.
Second, the overcapacity in terms of the amount of LigA avail-
able to M. smegmatis suggests that an irreversible inhibitor will
need to shut down LigA activity extremely efficiently. Pres-
ently, it is unclear if inhibitors of NAD-dependent DNA
ligases would be able to act so specifically and efficiently. Al-
though good progress is being made in the development of
potential compounds to target NAD-dependent DNA ligases
(2, 26–28), the concerns raised in this study make it clear that
these compounds will need to be tested in good experimental
models. The mycobacterial strains described here will provide
useful tools for such a detailed evaluation.
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